Trials / Unknown
UnknownNCT02776878
A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST
A Prospective, Single-arm, Multi-center Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in RefrActory MetAstatic Gastrointestinal Stromal Tumor
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 57 (estimated)
- Sponsor
- Peking University Cancer Hospital & Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether dasatinib is effective and safe in the treatment of refractory metastatic gastrointestinal stromal tumor
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dasatinib |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-10-01
- Completion
- 2018-05-01
- First posted
- 2016-05-18
- Last updated
- 2016-05-18
Locations
7 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02776878. Inclusion in this directory is not an endorsement.